Emergence of Covid-19 Is Expected To Offer Lucrative Growth Opportunities for Players in the Infection Surveillance Solutions Market

The global infection surveillance solutions market is predicted to register a significant increase in its annual revenue by next year. The global market is now growing due to the increasing popularity of dangerous, life-threatening diseases, including influenza, septic, tuberculosis, and even typhoid that has led to a massive increase in demand for health care professionals to detect these infections and control them before they spread.

The most obvious example of this is in the case of the Covid-19 outbreaks that are experienced by the public health organizations in many parts of the world. With the increasing number of cases of infectious diseases that are currently being reported, the demand for infection surveillance solutions is also continuously growing in response to the growing need for infection control. These solutions are essential in the fight against dangerous viral and bacterial infections that are rapidly spreading throughout the globe. Infection surveillance solutions are essential to identify the exact cause of an illness, in addition to their potential treatment methods and the effective management of the disease once diagnosed.

Market Dynamics 
High prevalence of hospital-acquired infections (HAIs) is expected to propel growth of the global infection surveillance solutions market over the forecast period. For instance, according to the study, ‘The prevalence of healthcare associated infections among adult inpatients at nineteen large Australian acute-care public hospitals: a point prevalence survey’, published in BMC Antimicrobial Resistance & Infection Control in July 2019, the prevalence of patients with a HAI was 9.9%. Hospital prevalence rates ranged from 5.7% to 17.0%.

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global infection surveillance solutions market. For instance, in October 2020, TestBoston study, a partnership between Brigham, the Broad Institute of MIT and Harvard and the MGB Center for COVID Innovation, was launched to increase coronavirus testing and surveillance in Boston, U.S.

Competitive Analysis 
Major players operating in the global infection surveillance solutions market include, Becton Dickson & Company, Baxter International Inc., Premier, Inc., Truven Health Analytics Inc. (IBM Watson), Gojo Industries, Inc., Wolters Kluwer N.V., Vigilanz Corporation, Atlas Medical Software (Rpoer Technologies), RLDatix, and Quantros, Inc.

Major players in the global infection surveillance solutions market are focused launching new products to enhance their market share. For instance, in May 2020, VigiLanz Corporation launched COVID Quick Start – a new solution that will enable hospitals to prepare for, prevent, and respond to the spread of COVID-19 and other respiratory viral illnesses.


 

Comments

Popular posts from this blog

Let’s know what is Automotive Internet of Things? Why it is gaining so much importance in the automotive industry?

Increasing Prevalence of Sleep Disorders to Augment Growth of the Sleep Aids Market

Increasing Demand for Disinfecting Wipes Is Expected To Boost the Household Wipes Market Growth